Insulet (PODD)

• Market cap: $17.4B
• 1 day: -1.94%
• 5 days: 0.31%
• 1 month: -6.91%
• 3 months: -24.63%
• 6 months: -26.24%
• Year to date: -12.83%
• 1 year: -7.67%
• 5 years: -8.75%
• 10 years: 704.86%
• Sector: Healthcare
• Industry: Medical Devices

About: Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Employees: 5,400